These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12216526)

  • 21. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV treatment series. Treatment interruptions. Reviewing what we've learned so far.
    Staszow K
    Posit Aware; 2006; 17(3):37-40. PubMed ID: 16791962
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of total lymphocyte count for monitoring response to antiretroviral therapy.
    Schreibman T; Friedland G
    Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early initiation of ART produces better clinical outcomes.
    Clin Infect Dis; 2009 Apr; 48(8):iii. PubMed ID: 19301458
    [No Abstract]   [Full Text] [Related]  

  • 25. Patient self-report as a marker of adherence to antiretroviral therapy.
    Ho CF; Fong OW; Wong KH
    Clin Infect Dis; 2002 Jun; 34(11):1534-5. PubMed ID: 12015702
    [No Abstract]   [Full Text] [Related]  

  • 26. Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
    De Beaudrap P; Etard JF; Diouf A; Ndiaye I; Guèye NF; Guèye PM; Sow PS; Mboup S; Ndoye I; Ecochard R; Eric D;
    Am J Trop Med Hyg; 2009 Jun; 80(6):1047-53. PubMed ID: 19478274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.
    Adjé-Touré CA; Cheingsong R; Garcìa-Lerma JG; Eholié S; Borget MY; Bouchez JM; Otten RA; Maurice C; Sassan-Morokro M; Ekpini RE; Nolan M; Chorba T; Heneine W; Nkengasong JN
    AIDS; 2003 Jul; 17 Suppl 3():S49-54. PubMed ID: 14565609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.
    Kaplan JE; Hanson DL; Cohn DL; Karon J; Buskin S; Thompson M; Fleming P; Dworkin MS;
    Clin Infect Dis; 2003 Oct; 37(7):951-8. PubMed ID: 13130408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective.
    Idoko JA; Agbaji O; Agaba P; Akolo C; Inuwa B; Hassan Z; Akintunde L; Badung B; Muazu M; Danang M; Imade G; Sankale JL; Kanki P
    Int J STD AIDS; 2007 Nov; 18(11):760-3. PubMed ID: 18005510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?
    Giordano TP; Wright JA; Hasan MQ; White AC; Graviss EA; Visnegarwala F
    Clin Infect Dis; 2003 Aug; 37(3):433-7. PubMed ID: 12884169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
    Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
    Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current perspectives in HIV therapeutics.
    Okulicz JF
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):12-3. PubMed ID: 21704879
    [No Abstract]   [Full Text] [Related]  

  • 35. Interleukin 2 and HIV RNA Levels.
    Go R; Steigbigel R
    Arch Intern Med; 2007 Oct; 167(19):2144-5; author reply 2145. PubMed ID: 17954814
    [No Abstract]   [Full Text] [Related]  

  • 36. When to start antiretroviral therapy: a swinging pendulum?
    Gallant JE
    Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A short-term trial of Didanosine, stavudine, and nevirapine combination therapy for human immunodeficiency virus infection].
    Zheng YH; Yang X; Chang WH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):390. PubMed ID: 14653126
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV/HCV coinfection: refining or redefining concepts?
    Peribañez Gonzalez M; Guimarães Pessôa M
    Liver Int; 2007 Feb; 27(1):1-3. PubMed ID: 17241374
    [No Abstract]   [Full Text] [Related]  

  • 40. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy.
    Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J
    Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.